OKYO Pharma Limited (LON:OKYO – Get Free Report) was down 24.3% on Friday . The company traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.40 ($0.02). Approximately 364,142 shares changed hands during mid-day trading, a decline of 16% from the average daily volume of 431,999 shares. The stock had previously closed at GBX 1.85 ($0.02).
OKYO Pharma Stock Performance
The company has a market capitalization of £23.24 million, a PE ratio of -140.00 and a beta of -0.06. The business’s fifty day moving average is GBX 1.40 and its two-hundred day moving average is GBX 1.40. The company has a current ratio of 0.83, a quick ratio of 2.65 and a debt-to-equity ratio of 1.65.
About OKYO Pharma
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain.
Further Reading
- Five stocks we like better than OKYO Pharma
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- Market Cap Calculator: How to Calculate Market Cap
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- What is the Hang Seng index?
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for OKYO Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OKYO Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
